| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.004 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.41 | 0.005 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.18 | 0.005 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.006 |